Q1 Earnings Forecast for ZNTL Issued By Leerink Partnrs
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) – Equities researchers at Leerink Partnrs reduced their Q1 2025 earnings per share estimates for shares of Zentalis Pharmaceuticals in a note issued to investors on Wednesday, March 26th. Leerink Partnrs analyst A. Berens now anticipates that the company will earn ($0.69) per share for the quarter, down […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) – Equities researchers at Leerink Partnrs reduced their Q1 2025 earnings per share estimates for shares of Zentalis Pharmaceuticals in a note issued to investors on Wednesday, March 26th. Leerink Partnrs analyst A. Berens now anticipates that the company will earn ($0.69) per share for the quarter, down […]
